Deracemization of Pipecolic Acid Amides
[13]
For reviews, see: a) F. Couty, Amino Acids 1999, 16, 297–320;
b) C. Kadouri-Puchot, S. Comesse, Amino Acids 2005, 29, 101–
130.
mandie), the Centre National de la Recherche Scientifique (CNRS),
and the Ministry of Education and Research.
[14]
[15]
[16]
J. Martin, M.-C. Lasne, J.-C. Plaquevent, L. Duhamel, Tetrahe-
dron Lett. 1997, 38, 7181–7182.
For reproducible results it was necessary to use a freshly
opened bottle of sBuLi.
T. Laube, J. D. Dunitz, D. Seebach, Helv. Chim. Acta 1985, 68,
1373–1393.
[1] Pioneer work: L. Duhamel, C. R. Acad. Sci. 1976, 282C, 125–
127.
[2] For reviews, see: a) L. Duhamel, P. Duhamel, J.-C. Launay, J.-
C. Plaquevent, Bull. Soc. Chim. Fr. 1984, 2, 421–430; b) C.
Fehr, Angew. Chem. Int. Ed. Engl. 1996, 35, 2567–2587; c) A.
Yanagisawa, K. Ishihara, H. Yamamoto, Synlett 1997, 411–
420; d) J. Eames, N. Weerasooriya, Tetrahedron: Asymmetry
2001, 12, 1–24; e) L. Duhamel, P. Duhamel, J.-C. Plaquevent,
Tetrahedron: Asymmetry 2004, 15, 3653–3691.
[3] For recent deracemizations through enantioselective proton-
ations, see: a) D. E. Ward, O. T. Akinnusi, I. Q. Alarcon, V.
Jheengut, J. Shen, J. W. Quail, Tetrahedron: Asymmetry 2004,
15, 2425–2430; b) G. S. Coumbarides, J. Eames, J. E. W.
Scheuermann, K. F. Sibbons, M. J. Suggate, M. Watkinson,
Bull. Chem. Soc. Jpn. 2005, 78, 906–909; c) R. Melgar-Fernan-
dez, E. Juaristi, Tetrahedron Lett. 2005, 46, 1221–1222; d) A.
Yanagisawa, T. Touge, T. Arai, Pure Appl. Chem. 2006, 78, 519–
523; e) C. Fehr, H. Randall, Chem. Biodiversity 2008, 5, 942–
957.
[4] a) A. Yanagisawa, T. Kikuchi, T. Watanabe, T. Kuribayashi, H.
Yamamoto, Synlett 1995, 372–374; b) C. H. Cheon, H. Yama-
moto, J. Am. Chem. Soc. 2008, 130, 9246–9247; c) K. Mitsu-
hashi, R. Ito, T. Arai, A. Yanagisawa, Org. Lett. 2006, 8, 1721–
1724; d) J. Gil, M. Medio-Simon, G. Mancha, G. Asensio, Eur.
J. Org. Chem. 2005, 1561–1567; e) Y. Yamashita, Y. Emura, K.
Odashima, K. Koga, Tetrahedron Lett. 2000, 41, 209–213; f)
M. Medio-Simon, P. Aleman, A. Cuenca, J. Gil, N. Rodriguez,
G. Asensio, ARKIVOC 2005, 266–286; g) T. Poisson, V. Dalla,
F. Marsais, G. Dupas, S. Oudeyer, V. Levacher, Angew. Chem.
Int. Ed. 2007, 46, 7090–7093; h) T. Poisson, S. Oudeyer, V.
Dalla, F. Marsais, V. Levacher, Synlett 2008, 2447–2450; i) M.
Morita, L. Drouin, R. Motoki, Y. Kimura, I. Fujimori, M.
Kanai, M. Shibasaki, J. Am. Chem. Soc. 2009, 131, 3858–3859.
[5] a) E. Vedejs, N. Lee, J. Am. Chem. Soc. 1991, 113, 5483–5485;
b) E. Vedejs, N. Lee, S. T. Sakata, J. Am. Chem. Soc. 1994, 116,
2175–2176; c) E. Vedejs, N. Lee, J. Am. Chem. Soc. 1995, 117,
891–900; d) E. Vedejs, A. W. Kruger, E. Suna, J. Org. Chem.
1999, 64, 7863–7870; e) E. Vedejs, A. W. Kruger, J. Org. Chem.
1998, 63, 2792–2793.
[6] G. S. Coumbarides, J. Eames, S. Ghilagaber, M. J. Suggate, Tet-
rahedron Lett. 2004, 45, 9469–9474.
[7] R. Melgar-Fernandez, R. Gonzalez-Olvera, E. Juaristi, Tetra-
hedron 2005, 61, 4329–4333.
[8] E. Vedejs, A. W. Kruger, N. Lee, S. T. Sakata, M. Stec, E. Suna,
J. Am. Chem. Soc. 2000, 122, 4602–4607, and references cited
therein.
[9] a) J. Martin, A. Deagostino, C. Perrio, F. Dauphin, C. Du-
candas, C. Morin, P.-L. Desbene, M.-C. Lasne, Bioorg. Med.
Chem. 2000, 8, 591–600; b) M.-C. Lasne, L. Barré, C. Huard,
C. Ducandas, E. T. MacKenzie, J. Labelled Compd. Ra-
diopharm. 1994, 35, 425.
[10] e.g a) S. Gupta, S. B. Krasnoff, D. W. Roberts, J. A. A.
Renwick, L. S. Brinen, J. Clardy, J. Am. Chem. Soc. 1991, 113,
707–709; b) K. K. Lee, J. B. Gloer, J. A. Scott, D. Malloch, J.
Org. Chem. 1995, 60, 5384–5385; c) D. L. Boger, J.-H. Chen,
K. W. Saionz, J. Am. Chem. Soc. 1996, 118, 1629–1644; d) W.
Gu, M. Cueto, P. R. Jensen, W. Fenical, R. B. Silverman, Tetra-
hedron 2007, 63, 6535–6541.
[11] P. J. Belshaw, S. D. Meyer, D. D. Johnson, D. Romo, Y. Ikeda,
M. Andrus, D. G. Alberg, L. W. Schultz, J. Clardy, S. L. Schrei-
ber, Synlett 1994, 381–392.
[12] See, for example: a) anesthetic (S)-bupivacaine: B. Adger, U.
Dyer, G. Hutton, M. Woods, Tetrahedron Lett. 1996, 37, 6399–
6402; b) anticonvulsants: B. Ho, P. M. Venkatarangan, S. F.
Cruse, C. N. Hinko, P. H. Andersen, A. M. Crider, A. A. Ad-
loo, D. S. Roane, J. P. Stables, Eur. J. Med. Chem. 1998, 33, 23–
31.
[17]
[18]
D. Seebach, Angew. Chem. Int. Ed. Engl. 1988, 27, 1624–1654.
IPR: the amine proton in an amine–anion complex becomes
reattached to the original carbon more rapidly than the carban-
ion can interact with the external proton source; see ref.[5,16]
P. Riviere, K. Koga, Tetrahedron Lett. 1997, 38, 7589–7592.
T. Yasukata, K. Koga, Tetrahedron: Asymmetry 1993, 4, 35–
38.
G. Asensio, P. A. Aleman, L. R. Domingo, M. Medio-Simón,
Tetrahedron Lett. 1998, 39, 3277–3280, and references cited
therein.
A. Yanagisawa, T. Kikuchi, H. Yamamoto, Synlett 1998, 174–
176.
a) M. J. Schlosser, J. Organomet. Chem. 1967, 8, 9; b) M.
Schlosser, Organometallics in Synthesis Wiley, Chichester, 1994,
p. 72.
W. Bauer, T. Laube, D. Seebach, Chem. Ber. 1985, 118, 764–
773.
J.-Y. Valnot, J. Maddaluno, Patai Series: The Chemistry of
Organolithium Compounds, vol. 2, in: The Chemistry of Func-
tional Groups (Eds.: Z. Rappoport, I. Marek), Wiley, Chiches-
ter, 2006, p. 525.
For a recent characterization of a chiral enolate aggregate, see:
D. Li, C. Sun, P. G. Williard, J. Am. Chem. Soc. 2008, 130,
11726–11736, and references cited therein.
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
P. G. Williard, M. J. Hintze, J. Am. Chem. Soc. 1987, 109,
5539–5541.
From the 13C NMR spectrum, the (E)-4a/(Z)-4a ratio was
higher than 80:20.
For recent chiral proton sources in deracemization through
asymmetric protonation: a) β-hydroxy esters: B. M. Kim, H.
Kim, W. Kim, K. Y. Im, J. K. Park, J. Org. Chem. 2004, 69,
5104–5107; b) C2-symmetric sulfonamides: E. Boyd, G. S. Co-
umbarides, J. Eames, A. Hay, R. V. H. Jones, R. A. Stenson,
M. J. Suggate, Tetrahedron Lett. 2004, 45, 9465–9468.
A. Yanagisawa, T. Kikuchi, T. Kuribayashi, H. Yamamoto,
Tetrahedron 1998, 54, 10253–10264.
K. Flinois, Y. Yuan, C. Bastide, A. Harrison-Marchand, J.
Maddaluno, Tetrahedron 2002, 58, 4707–4716.
A. Yanagisawa, T. Touge, T. Arai, Angew. Chem. Int. Ed. 2005,
44, 1546–1548.
An alternative to the aniline derivative (+)-5 has been sug-
gested: E. Vedejs, P. Trapencieris, E. Suna, J. Org. Chem. 1999,
64, 6724–6729.
For C-deuteriation of ketone enolates, see: a) G. S. Coumbar-
ides, J. Eames, N. Weerasooriya, J. Labelled Compd. Ra-
diopharm. 2002, 45, 965–973; b) J. Eames, G. S. Coumbarides,
M. J. Suggate, N. Weerasooriya, Eur. J. Org. Chem. 2003, 634–
641; c) G. S. Coumbarides, J. Eames, M. J. Suggate, J. Labelled
Compd. Radiopharm. 2004, 47, 359–371; d) G. S. Coumbarides,
J. Eames, M. J. Suggate, N. Weerasooriya, J. Labelled Compd.
Radiopharm. 2006, 49, 641–652; e) M. Begum, S. Chavda, G. S.
Coumbarides, M. Dingan, J. Eames, M. J. Suggate, N. Weera-
sooriya, J. Labelled Compd. Radiopharm. 2006, 49, 707–732.
a) J. Eames, N. Weerasooriya, Tetrahedron Lett. 2000, 41, 521–
523; b) J. Eames, N. Weerasooriya, Chirality 1999, 11, 787–789.
For intramolecular vs. intermolecular proton delivery in keton-
ization of enolates, see: a) H. E. Zimmerman, J. Cheng, Org.
Lett. 2005, 7, 2595–2597; b) H. E. Zimmerman, J. Cheng, J.
Org. Chem. 2006, 71, 873–882 and references cited therein.
[30]
[31]
[32]
[33]
[34]
[35]
[36]
Eur. J. Org. Chem. 2009, 5414–5422
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5421